Men in the enzalutamide group also had better clinical progression-free survival (PFS), which the research team defined as the time until the return of disease-related symptoms, the detection of new metastases on imaging scans, or the initiation of another cancer treatment for prostate cancer, whichever came first
including behavioural interventions like energy restriction and exercise) not only in type 2 diabetes but also in non-diabetic obese patients
If there is any doubt, do not use the product
In general, drinking too much cancels out many of the benefits that GLP-1 aims to provide, including controlling appetite and improving metabolism
It may simply mean your body needs more time to respond
So while the anti-inflammatory bonus is exciting, these drugs should still be seen as tools, not miracle cures